IRIS
PALMIERI, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.709
EU - Europa 583
AS - Asia 314
OC - Oceania 7
SA - Sud America 7
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.626
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.697
IT - Italia 315
SG - Singapore 173
IE - Irlanda 91
CN - Cina 54
RU - Federazione Russa 53
GB - Regno Unito 21
DE - Germania 20
FI - Finlandia 16
ID - Indonesia 16
KR - Corea 15
FR - Francia 14
TH - Thailandia 12
IN - India 10
NL - Olanda 9
BE - Belgio 8
CA - Canada 8
SE - Svezia 8
PH - Filippine 7
AU - Australia 6
CZ - Repubblica Ceca 5
SA - Arabia Saudita 5
ES - Italia 4
HK - Hong Kong 4
IR - Iran 4
MX - Messico 4
PK - Pakistan 4
BR - Brasile 3
LU - Lussemburgo 3
SK - Slovacchia (Repubblica Slovacca) 3
BD - Bangladesh 2
CO - Colombia 2
HR - Croazia 2
IQ - Iraq 2
MY - Malesia 2
PL - Polonia 2
RS - Serbia 2
UA - Ucraina 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
JP - Giappone 1
LV - Lettonia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
SD - Sudan 1
TN - Tunisia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 2.626
Salva come PNG Salva come JPEG
Città #
Houston 332
Wilmington 330
Singapore 156
Chandler 152
Rome 126
Fairfield 91
New York 87
Dublin 69
Engelhard 49
Ashburn 46
Santa Clara 45
Woodbridge 43
Medford 41
Ann Arbor 37
Beijing 33
Cambridge 33
Seattle 33
Boardman 27
Milan 24
Lawrence 20
Jakarta 16
San Diego 16
Creede 15
Seoul 15
Bang Bai Mai 11
Moscow 11
Lappeenranta 10
Billings 8
Brussels 7
Dearborn 7
Turin 7
London 6
Toronto 6
Brno 5
Helsinki 5
Los Angeles 5
Marseille 5
Pune 5
Roebling 5
Shenzhen 5
Bari Sardo 4
Bologna 4
Frankfurt am Main 4
Jeddah 4
Manila 4
Amsterdam 3
Bari 3
Brooklyn 3
Lahore 3
Melbourne 3
Mülheim 3
Pescorocchiano 3
Pignola 3
Pontedera 3
Redditch 3
Redwood City 3
Shanghai 3
Villasanta 3
Arvada 2
Baghdad 2
Bratislava 2
Campinas 2
Center 2
Chiesina Uzzanese 2
Clearwater 2
Colorado Springs 2
Council Bluffs 2
Durham 2
Fiuggi 2
Florence 2
Genazzano 2
Guangzhou 2
Halifax 2
Kilburn 2
Krummesse 2
Kuala Lumpur 2
Los Banos 2
Luxembourg 2
Matawan 2
Menlo Park 2
Monte Vista 2
Montemarciano 2
Mountain View 2
Munich 2
Newcastle 2
Olympia 2
Parma 2
Poggiomarino 2
Reggio Emilia 2
Senago 2
Tallahassee 2
Thrissur 2
Udine 2
Virovitica 2
Anagni 1
Anaheim 1
Ancona 1
Antwerp 1
Ardea 1
Auckland 1
Totale 2.081
Salva come PNG Salva come JPEG
Nome #
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE 326
An evaluation of enasidenib for the treatment of acute myeloid leukemia 188
WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine 183
Therapeutic Choice in Older Patients with Acute Myeloid Leukemia: A Matter of Fitness 174
The Efficacy and Safety of Lenalidomide plus Rituximab in an Orbital Relapse of Diffuse Large B-Cell Lymphoma 152
Primary Cutaneous Anaplastic Large Cell Lymphoma of the Oral Cavity Successfully Treated with Brentuximab Vedotin 151
Clinical relevance of an objective - limit of detection - limit of quantification - based flow cytometry approach for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial 128
Current strategies for detection and approach to measurable residual disease in Acute Myeloid Leukemia 102
FEVER OF UNKNOWN ORIGIN AND MULTIDRUG-RESISTANT ORGANISMS COLONIZATION IN AML PATIENTS 96
Case report: A Saprochaete clavata (Magnusiomyces clavatus) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcoma 89
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation 72
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in {SARS}-{CoV}-2 infected patients: a single center study 69
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML 67
Acute Leukemia diagnosis during the Covid-19 pandemic 67
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol 64
Ponatinib and Risk of Thrombotic Events: In Vitro Study on Platelet Functions 63
CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia 59
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia 53
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients 53
Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy 53
ACUTE LEUKEMIA AND LATENT TUBERCULOSIS INFECTION IN ITALY: QUANTIFERON-TB TEST SCREENING IN A LOW TUBERCULOSIS INCIDENCE COUNTRY 48
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia 48
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML 43
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia 42
Pulmonary function testing for fitness assessment in asymptomatic adults with newly diagnosed acute myeloid leukemia 37
Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia 37
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION 32
Occult central nervous system involvement guides therapeutic choices in blastic plasmacytoid dendritic cell neoplasms 32
In BCR-ABL1 Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia 32
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy 30
An Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor JAK2 V617F Mutated Clone 29
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience 29
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis 28
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 26
Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML) 25
Risk-adapted MRD-directed therapy for young acute myeloid leukemia adults: 6-year update of the GIMEMA AML1310 trial 24
The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19 23
Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations 22
The response to oxidative damage correlates with driver mutations and clinical outcome in patients with myelofibrosis 19
Editorial: Measurable residual disease in hematologic malignancies 11
Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm 2
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study 1
Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation 1
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials 1
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts 1
Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm 1
Allogeneic stem cell transplantation in patients with a prior history of prostate cancer 1
Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML 1
Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms 1
Totale 2.836
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.757
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020336 0 0 0 0 0 26 65 40 46 68 45 46
2020/2021510 46 51 61 59 61 73 75 44 13 8 9 10
2021/2022325 4 11 13 3 9 45 16 17 52 31 20 104
2022/2023575 54 38 47 40 49 93 86 50 67 19 19 13
2023/2024533 26 8 169 9 20 103 17 45 30 16 20 70
2024/2025476 48 168 114 75 25 46 0 0 0 0 0 0
Totale 2.836